Sort
10,829 grants matching “car t”
Addressing High School Marijuana Use in Context of Increasing Social Acceptance
$232,963Bettina Marga Friese · Pacific Institute For Res And Evaluation · R34 · FY2015 · DA
Phase III, Multicenter, Randomized, Double-Blind Study of Duvelisib as Cytokine Release Syndrome Prophylaxis in Patients with Large Cell or Mantle Cell Lymphoma Undergoing CAR T-Cell Therapies
$232,941Iskra Pusic · Washington University · UG1 · FY2025 · HL
Placental P-gp/BCRP in fetal drug exposure and regulation by hormones/xenobiotic
$232,782Qingcheng Mao · University Of Washington · P01 · FY2013 · DA
Cytoxic and Genotoxic Effects of Manufactured Nanoparticles on Stem Cells
$232,746Yiling Hong · Western University Of Health Sciences · R15 · FY2011 · ES
Technology for HIV Prevention Among Vulnerable Men in India
$232,650Matthew James Mimiaga · Fenway Community Health Center · R21 · FY2011 · DA
Pregnenolone as a Treatment for Cannabis Intoxication
$232,625David Wolinsky · Johns Hopkins University · R21 · FY2025 · DA
Text Message Physical Activity Intervention to Treat Cognitive Deficits in HIV
$232,500Brook Henry · University Of California, San Diego · R21 · FY2013 · MH
Assessing the impact of glaucoma and its treatment on the person
$232,500David C Musch · University Of Michigan At Ann Arbor · R21 · FY2016 · EY
A Web-Based Approach to Evaluating HIV-Associated Neurocognitive Disorders
$232,500Steven P Woods · University Of California, San Diego · R21 · FY2012 · MH
Current-Use Flame Retardants: Maternal Exposure and Neurodevelopment in Children
$232,475Asa Bradman · University Of California Berkeley · R21 · FY2014 · ES
Armed Replicating Ad for Breast Cancer Bone Metastasis
$232,436Joanne T Douglas · University Of Alabama At Birmingham · R01 · FY2006 · CA
Project 4 Treatment of Advanced Ovarian Cancer Using Gene-Edited NK CAR Cells
$232,427Branden S Moriarity · Mayo Clinic Rochester · P50 · FY2023 · CA
Can systems science explain variation in state alcohol and traffic policies?
$232,328James Macinko · New York University · R21 · FY2013 · AA
Targeting MUC1-C for the Treatment of Small Cell Lung Cancer Progression
$232,259Donald W. Kufe · Dana-Farber Cancer Inst · R21 · FY2022 · CA
Transductionally Redirected and Transcriptionally Restricted Adenovirus
$232,233Harvey R. Herschman · University Of California Los Angeles · P50 · FY2007 · CA
Project 4: Off-the-shelf engineered cord blood-derived natural killer cells for the treatment acute lymphoblastic leukemia
$232,221Katy Rezvani · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Project 2: Anti-PR1 Immune Therapy for Myeloid Leukemia
$232,219Jeffrey J Molldrem · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Transductionally Redirected and Transcriptionally Restricted Adenovirus
$232,188Harvey R. Herschman · University Of California Los Angeles · P50 · FY2008 · CA
Stimuli-responsive reagents for improved cell isolations and activations
$232,149Barrett J Nehilla · Nexgenia, Inc. · R43 · FY2016 · AI
EAGER: Joint Modeling and Querying of Social Media and Video Data
$232,000Evangelos Christidis · University Of California-Riverside · · FY2017 · CSE
Technology for HIV Prevention Among Vulnerable Men in India
$231,938Matthew James Mimiaga · Fenway Community Health Center · R21 · FY2012 · DA
Optimizing Cancer Immunotherapy Safety and Efficacy using Genome Editing
$231,891Benjamin Peter Kleinstiver · Massachusetts General Hospital · R00 · FY2019 · CA
Addressing High School Marijuana Use in Context of Increasing Social Acceptance
$231,866Bettina Marga Friese · Pacific Institute For Res And Evaluation · R34 · FY2016 · DA
Assessing space and feature based attention with fMRI and multivoxel pattern anal
$231,750John T Serences · University Of California, San Diego · R21 · FY2010 · MH
A Mobile Behavioral Monitoring Intervention for Bipolar Disorder
$231,750Evan H. Goulding · Northwestern University At Chicago · R34 · FY2015 · MH